All Pharma News
price-trendAsk Us
Fiscal Year 2023: Exyte experiences strong growth in Europe and the USA

Fiscal Year 2023: Exyte experiences strong growth in Europe and the USA
PR NEWSWIRE
09 Apr 2024
Share Share
Exyte with remarkable 6M/2022 results and uplifted year-end outlook

Exyte with remarkable 6M/2022 results and uplifted year-end outlook
PRNEWSWIRE
16 Aug 2022
Share Share
Wacker Chemie invests 100 million euros in mRNA factory

Wacker Chemie invests 100 million euros in mRNA factory
Zuzanna Szymanska REUTERS
05 Jul 2022
Share Share
Exyte Closes 2021 with Record Order Intake

Exyte Closes 2021 with Record Order Intake
PRNEWSWIRE
27 Jan 2022
Share Share